# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020, Paragraph 157

Extent: E+W+S+N.I.

In regulation 203 (amendment of regulation 260 (package leaflets))—
(a) in paragraph (2), in the inserted paragraph (1A), after the first reference to “advanced therapy medicinal product” insert “ for sale or supply in Great Britain only ”;
(b) in paragraph (3), in the inserted text, after “advanced therapy medicinal product,” insert “ for sale or supply in Great Britain only ”;
(c) in paragraph (4)—
(i) omit “, Article 126a authorisation”;
(ii) after “UK marketing authorisation” insert “ , EU marketing authorisation, ”.

---
Source: https://www.legislation.gov.uk/uksi/2020/1488/schedule/2/paragraph/157 (the official version)
Page: https://openlegislation.uk/human-medicines-amendment-etc-eu-exit-regulations-2020/schedule-2/paragraph-157
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.